Feeling Good in Your Own Skin is a free educational event for patients, caregivers and survivors to learn about advancements in melanoma research, clinical care, and survivorship.
Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research.
With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. Since the AIDS drug is already FDA approved, clinical testing in melanoma patients could potentially begin sooner than if it was a novel […]
Gowtham Jonna, M.D., senior retina fellow at the Vanderbilt Eye Institute, recently received a VitreoRetinal Surgery Foundation (VRSF) Research Award. Gowtham Jonna, M.D. The purpose of the award is to support young investigators conducting research on macular and retinal disease and to encourage a career devoted to retinal disease and research. Jonna is working on […]
Vanderbilt University cancer researcher Ann Richmond, Ph.D., has won the 2016 William S. Middleton Award, the highest honor for scientific achievement bestowed by the Biomedical Laboratory Research and Development Service of the U.S. Department of Veterans Affairs (VA). Richmond is Ingram Professor of Cancer Research and professor of Cancer Biology and Medicine at Vanderbilt University […]
The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. “Nationwide we’re seeing great promise with this approach […]
Rob Schieber and Jordan Lawhead each moved to Nashville to pursue a career in music. Songwriter and publisher Kris Bergsnes introduced them knowing they were both cancer survivors. But a chance meeting in a patient waiting room at Vanderbilt-Ingram Cancer Center (VICC) united the two men in their cancer journey as well as in friendship […]
Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during an upcoming community event. “Precision Medicine in Cancer: At the Crossroads of Research and Treatment for Patients” will be held Tuesday, May 10, from 5:30 to 7:30 p.m. at the Vanderbilt Student Life Center, 310 25th Ave. S. The public is […]
Anti-PD-1 therapy – a treatment that stimulates the immune system to attack tumors – produces responses in up to 40 percent of melanoma patients. Predictive markers of response are needed to optimize patient selection, improve treatment decision-making and minimize costs. Justin Balko, Pharm.D., Ph.D., Douglas Johnson, M.D., and colleagues hypothesized that tumor expression of MHC-I […]
Chemotherapy and targeted anti-cancer drugs can induce tumor cell senescence. Although cell proliferation is shut down in senescent cells, there is enhanced expression of secreted factors that may promote or suppress tumor growth. Anna Vilgelm, Ph.D., and colleagues explored how therapy-induced senescence impacts the therapeutic response of melanoma. Using mouse models, the researchers assessed gene […]